| 08-03-2023 |
de Jonge Investments |
United Therapeutics Corporation - Common Stock |
18 |
$222.64 |
$4,007.52 |
| 09-03-2023 |
de Jonge Investments |
United Therapeutics Corporation - Common Stock |
-18 |
$225.26 |
-$4,054.68 |
| 09-03-2023 |
de Jonge Investments |
United Therapeutics Corporation - Common Stock |
18 |
$225.26 |
$4,054.68 |
| 10-03-2023 |
de Jonge Investments |
United Therapeutics Corporation - Common Stock |
-18 |
$228.77 |
-$4,117.86 |
| 04-04-2023 |
de Jonge Investments |
United Therapeutics Corporation - Common Stock |
25 |
$227.18 |
$5,679.50 |
| 05-04-2023 |
de Jonge Investments |
United Therapeutics Corporation - Common Stock |
-25 |
$232.99 |
-$5,824.75 |
| 25-09-2023 |
de Jonge Investments |
United Therapeutics Corporation - Common Stock |
761 |
$224.06 |
$170,509.66 |
| 26-09-2023 |
de Jonge Investments |
United Therapeutics Corporation - Common Stock |
-761 |
$229.91 |
-$174,961.51 |
| 04-10-2023 |
de Jonge Investments |
United Therapeutics Corporation - Common Stock |
847 |
$221.93 |
$187,974.70 |
| 05-10-2023 |
de Jonge Investments |
United Therapeutics Corporation - Common Stock |
-847 |
$228.29 |
-$193,361.62 |
